COmBining memantine And cholinesterase inhibitors in Lewy body dementia Treatment trial (COBALT) is a clinical trial, which aims to find out if adding Memantine to a cholinesterase inhibitor (either donepezil, rivastigmine and galantamine) improves overall health and functioning for people with Dementia with Lewy Bodies (DLB) or Parkinson’s Disease Dementia. (PDD)

Please explore the headings above to find out more about COBALT, where it is taking place and who can participate.

 The views and opinions expressed on this website are those of the authors and do not necessarily reflect those of the HTA, NIHR, NHS or the Department of Health.